Chrysalyne D. Schmults
Springer Berlin Heidelberg
e druk, 2016
9783662470800
High-Risk Cutaneous Squamous Cell Carcinoma
A Practical Guide for Patient Management
Specificaties
Gebonden, 200 blz.
|
Engels
Springer Berlin Heidelberg |
2016
ISBN13: 9783662470800
Rubricering
Verwachte levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
This book is a cutting-edge resource that provides clinicians with the up-to-date practical knowledge required in order to manage SCC patients optimally. It summarizes newly available information relating to the definition of high-risk SCC, its pathophysiologic underpinnings, and its management. New prognostic information and staging systems are summarized that enable high-risk tumors to be defined more precisely than ever before. Many helpful tips are provided on the practical management of challenging cases, including multiple tumors/field cancerization, high-risk tumors, nodal metastases, and unresectable disease. The authors are all acknowledged experts in the emerging field of high-risk and advanced SCC.
Specificaties
ISBN13:9783662470800
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:200
Uitgever:Springer Berlin Heidelberg
Inhoudsopgave
<p>Table of Contents</p>
<p> </p>
<p>High-Risk Cutaneous Squamous Cell Carcinoma: A Practical Guide for Patient Management </p>
<p> </p>
<p> </p>
<p> </p>
<p>Chrysalyne D. Schmults, editor</p>
<p> </p>
<p> </p>
<p>Dedication </p>
<p>Preface</p>
<p> </p>
<p> </p>
<p> </p>
<p>Part I. Defining the Problem of High-risk SCC</p>
<p> </p>
<ol> <li>Epidemiology and Outcomes of Cutaneous Squamous Cell Carcinoma</li> </ol> <p>Pritesh S. Karia</p>
<p> </p>
<ol> <li>Tumor Staging Systems and Prognostic Stratification</li> </ol> <p>Anokhi Jambusaria-Pahlajani</p>
<p> </p>
<p>Part II. The Science of SCC</p>
<p> </p>
<ol> <li>Genomics of SCC: Tumor Formation, Progression, and Future Therapeutic Implications for High-risk Cutaneous Squamous Cell Carcinoma</li> </ol> <p>Catherine Anne Harwood, Charlotte Proby, Sarah Arron</p>
<p> </p>
<ol> <li>Molecular and Cellular Interplay in SCC Including Immunomodulation and Clinical Implications</li> </ol> <p>Valerie Yanofsky, John A. Carucci, Günther F.L. Hofbauer</p>
<p> </p>
Part III. Management of High-risk SCC</p>
<p> </p>
<ol> <li>Management of Patients with Multiple SCCs/Field Cancerization</li> </ol> <p>Sasha Jenkins Haberle, Lauren Rimoin, Myrto Georgia Trakatelli, Fiona Zwald</p>
<p> </p>
<ol> <li>Management of High-Risk Primary Tumors including Nodal Staging</li> </ol> <p>Vishal Anil Patel, Christian L. Baum, Désirée Ratner</p>
<p> </p>
<ol> <li>Management of Local Recurrence and In-transit Metastasis</li> </ol> <p>Vitaly Terushkin, John A. Carucci</p>
<p> </p>
<ol> <li>Management of Nodal Metastases </li> </ol> <p>Michael Veness, Julie Howle </p>
<p> </p>
<ol> <li>Management of Widely Metastatic and Unresectable Cutaneous Squamous Cell Carcinoma</li> </ol> <p>Glenn J. Hanna, Emily Stamell Ruiz, Jochen H. Lorch</p>
<p> </p>
<ol> <li>Immune Dysfunction and Immunosuppression: Impacts on SCC Incidence, Prognosis, and Management</li> </ol> <p>Travis W. Blalock, Thomas Stasko</p>
<p> </p>
<p>High-Risk Cutaneous Squamous Cell Carcinoma: A Practical Guide for Patient Management </p>
<p> </p>
<p> </p>
<p> </p>
<p>Chrysalyne D. Schmults, editor</p>
<p> </p>
<p> </p>
<p>Dedication </p>
<p>Preface</p>
<p> </p>
<p> </p>
<p> </p>
<p>Part I. Defining the Problem of High-risk SCC</p>
<p> </p>
<ol> <li>Epidemiology and Outcomes of Cutaneous Squamous Cell Carcinoma</li> </ol> <p>Pritesh S. Karia</p>
<p> </p>
<ol> <li>Tumor Staging Systems and Prognostic Stratification</li> </ol> <p>Anokhi Jambusaria-Pahlajani</p>
<p> </p>
<p>Part II. The Science of SCC</p>
<p> </p>
<ol> <li>Genomics of SCC: Tumor Formation, Progression, and Future Therapeutic Implications for High-risk Cutaneous Squamous Cell Carcinoma</li> </ol> <p>Catherine Anne Harwood, Charlotte Proby, Sarah Arron</p>
<p> </p>
<ol> <li>Molecular and Cellular Interplay in SCC Including Immunomodulation and Clinical Implications</li> </ol> <p>Valerie Yanofsky, John A. Carucci, Günther F.L. Hofbauer</p>
<p> </p>
Part III. Management of High-risk SCC</p>
<p> </p>
<ol> <li>Management of Patients with Multiple SCCs/Field Cancerization</li> </ol> <p>Sasha Jenkins Haberle, Lauren Rimoin, Myrto Georgia Trakatelli, Fiona Zwald</p>
<p> </p>
<ol> <li>Management of High-Risk Primary Tumors including Nodal Staging</li> </ol> <p>Vishal Anil Patel, Christian L. Baum, Désirée Ratner</p>
<p> </p>
<ol> <li>Management of Local Recurrence and In-transit Metastasis</li> </ol> <p>Vitaly Terushkin, John A. Carucci</p>
<p> </p>
<ol> <li>Management of Nodal Metastases </li> </ol> <p>Michael Veness, Julie Howle </p>
<p> </p>
<ol> <li>Management of Widely Metastatic and Unresectable Cutaneous Squamous Cell Carcinoma</li> </ol> <p>Glenn J. Hanna, Emily Stamell Ruiz, Jochen H. Lorch</p>
<p> </p>
<ol> <li>Immune Dysfunction and Immunosuppression: Impacts on SCC Incidence, Prognosis, and Management</li> </ol> <p>Travis W. Blalock, Thomas Stasko</p>